Recalcitrant hyperkeratotic verrucae in a renal transplant recipient clearing with cessation of immunosuppression

Organ transplant recipients are at high risk of cutaneous wart development.1-3 The presence of viral warts is determined by the type of immunosuppressive therapy, its dosage, and its duration,1,2 and the incidence varies from 24% to 53%.3-5 Up to 50% of renal transplant recipients with graft survival greater than 5 years have warts.3